IGCAN Directory
login/create account
DonateHome > About > News
Latest Story
Recent Stories
Renew or Join
Its membership renewal season and the perfect time to join IGCS if you are not currently a member. All dues payments are applied to the 2026 membership term. IGCS provides year-round education, mentorship and training opportunities, and most recently, advocacy and outreach programming in support of our mission.
New & Updated: Preinvasive Disease Program Supporting Cervical Cancer Elimination
The IGCS Preinvasive Disease Program has just been upgraded.Modules from the 2nd phase of the online course (Advanced Theory) have undergone a major refresh — with streamlined lectures, new topics, and the most current global guidelines to keep you at the forefront of care. Now available in the IGCS Education360 Learning Portal, this program represents one of the most thorough educational programs in the world for teaching preinvasive disease knowledge and clinical skills.Enroll in the IGCS Preinvasive Disease ProgramNew & Updated TopicsPhase 2: Advanced Theory now includes 19 required and 5 optional lectures delivered by world-leading experts. Among the highlights:WHO and ASCO guideline updates for screening and treatmentHPV-related preinvasive disease and cancer in women living with HIVUpdated terminology in cytology, histopathology, and colposcopyNew diagnostic strategies, including self-sample HPV testingContemporary real-world vaccine outcomes and treatment approaches, from ablation to excisionNew lectures, including:• Follow-up after Treatment – Dr. Dawit Worku• Evidence on Single Dose Vaccine – Dr. Phil Castle• Anal Screening – Dr. Lisa FlowersNow Available on Education360 Learning PortalShorter, more focused lectures that highlight the most essential contentFresh updates across nearly every lecture, plus 4 brand-new lecturesBetter participant experience with easier navigation and seamless translations in 12 languagesNo retake required — past participants now have access to all updatesEnroll Today!The Program’s Global ImpactThis program (free for IGCS Members) provides a framework…
Position Paper: Spotlight on Uterine Cancer
Uterine cancer is the second most common gynecological cancer globally, but often it is missing from national cancer plans and global health priorities. Without political attention, there is no accountability, no funding, and no progress. The position paper on uterine cancer “Spotlight on uterine cancer: Shaping access to equitable and high-quality care”, which IGCS co-authored with like-minded organizations from around the world, including AstraZeneca, is a call to governments and policymakers everywhere: the time to act is now. Launched at the 2025 Concordia Annual Summit, held alongside the United Nations General Assembly High-Level Meeting, the paper sets out clear, actionable steps to change the trajectory of uterine cancer. It calls for governments and health systems to integrate uterine cancer into national health strategies, invest in early detection so more women are diagnosed in time, and guarantee equitable access to care options and innovation. These are practical changes that can save lives, reduce disparities, and bring uterine cancer out of the shadows. We urge policymakers to listen, to act, and to put uterine cancer where it belongs – on the global health agenda. Position Paper – Spotlight on Uterine Cancer: Shaping Access to High Quality Care Released: September 22, 2025 View Paper This report reflects the contributions of IGCS Members, whose perspectives and expertise helped shape its recommendations. Abhishek Shankar —…
Upcoming Events
More Stories
Latin America is a huge area with an enormous number of women with gynecologic cancers. Regional leaders spent a great deal of time and effort engaging with their colleagues about the Strategic Alliance Program and ultimately included nearly 400 new members who will be joining IGCS. I personally want to thank every one of them for their vision and their commitment to the women they treat.
As IGCS continues with the desire to be the global voice of Gynecologic Oncology we are pleased to announce that the Israeli Society of Gynecologic Oncology (ISGO) has joined our Strategic Alliance Partnership Program. ISGO is a multidisciplinary society including gynecological oncologists, medical oncologists and radiotherapists dedicated to the treatment of women with gynecological cancer, which includes 20 affiliated centres.
Please join me in welcoming the Indonesian Society of Gynecologic Oncology (INASGO) as a new Strategic Alliance Partner. INASGO was founded in 2000 with a current membership of 110 gynecologic oncology practitioners. We are thrilled to welcome them to the IGCS community and are excited to engage with the INASGO leadership Prof Andrijono and Prof Purwoto to hear from them their vision for the future of gynecologic oncology, pathology, and radiation oncology in Indonesia. We look forward to participating in their strategic planning process and to identify ways we can work together towards improving the health and care of Indonesian women.
Please welcome the Association of Oncologists of Uzbekistan as a new Strategic Alliance Partner. Under the leadership of Professor Tilliashahov Mirzagaleb Nigmatovich, Chairman of the AOUZ board, a new strategic alliance partnership with IGCS has been formed. The Association of Oncologists of Uzbekistan was founded on August 7th, 2003. AOUZ is a non-governmental, non-commercial organization, involving a voluntary scientific and educational union of specialists in the sphere of theoretical and practical oncology.
As we come to the end of 2017, please join me in welcoming the Thai Gynecologic Cancer Society (TGCS) as a new Strategic Alliance Partner of the IGCS. The Thai Gynecological Cancer Society was founded with the mission, “To Better the Health of Thai Women with Reproductive Cancer.” Their focus on patient care, education and disseminating information to their members and to the public is perfectly aligned with the IGCS mission.
The Pan-Arabian Research Society of Gynecological Oncology (PARSGO) is the newest IGCS Strategic Alliance Partner. PARSGO includes sixty-one members with a professional interest in the prevention, treatment, and research of gynecological cancers from centers across the Arab world. This is the first Strategic Alliance Partnership that includes a multi-country membership in areas where IGCS has typically had a low penetration. PARSGO members are from centers within the following countries: Algeria, Bahrain, Mauritania, Morocco, Sudan, Syria, Tunisia, Oman, UAE, Palestine, Qatar, Yemen, Saudi, Egypt, Iraq, Djibouti, Somalia, Jordan, Kuwait, Lebanon, Libya and Comoro Islands. Members also include gynecologic oncology professionals of Arabic heritage who practice in other parts of the world but are committed to the PARSGO mission.
It has been such a pleasure over the last year to continue to meet and engage with IGCS members all over the globe. I recently had the honor of traveling to Central Asia to learn more about this beautiful region, the incidence of gynecologic oncology and the opportunity to get to know the wonderful people who live there and their strong affinity to IGCS. Under the leadership of Dilyara Kaidarova MD, PhD, Director of the Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan a meeting was held with representatives from Russia, Georgia, Uzbekistan, Tadzhikistan, Ukraine, Kyrgyzstan, and Center for Global Health, National Cancer Institute.